| Primary |
| Premedication |
27.2% |
| Drug Use For Unknown Indication |
17.5% |
| Product Used For Unknown Indication |
16.0% |
| Breast Cancer |
9.1% |
| Prophylaxis |
4.1% |
| Prophylaxis Of Nausea And Vomiting |
4.1% |
| Chemotherapy |
4.0% |
| Vomiting |
3.5% |
| Nausea |
2.4% |
| Adenocarcinoma |
2.0% |
| Ovarian Cancer |
1.8% |
| Colon Cancer |
1.7% |
| Hodgkin's Disease |
1.1% |
| Pain |
1.0% |
| Abdominal Pain |
0.9% |
| Lymphoma |
0.8% |
| Acute Lymphocytic Leukaemia |
0.7% |
| Colon Neoplasm |
0.7% |
| Neoplasm Malignant |
0.7% |
| Pancreatic Carcinoma |
0.7% |
|
| Vomiting |
20.3% |
| Toxic Skin Eruption |
8.6% |
| Thrombocytopenia |
7.8% |
| Paraesthesia |
5.5% |
| Pruritus |
5.5% |
| Transaminases Increased |
5.5% |
| Urticaria |
5.5% |
| Malaise |
4.7% |
| Cardiac Arrest |
3.9% |
| Pyrexia |
3.9% |
| Respiratory Distress |
3.9% |
| Hepatocellular Injury |
3.1% |
| Hypersensitivity |
3.1% |
| Placental Disorder |
3.1% |
| Rash Maculo-papular |
3.1% |
| Syncope Vasovagal |
3.1% |
| Drug Exposure During Pregnancy |
2.3% |
| Jaundice |
2.3% |
| Oxygen Saturation Decreased |
2.3% |
| Pallor |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
28.3% |
| Drug Use For Unknown Indication |
16.2% |
| Premedication |
13.1% |
| Breast Cancer |
7.3% |
| Lymphoma |
3.9% |
| Acute Myeloid Leukaemia |
3.1% |
| Adenocarcinoma |
2.8% |
| Vomiting |
2.5% |
| Foetal Exposure During Pregnancy |
2.5% |
| Maternal Exposure Timing Unspecified |
2.5% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Colon Cancer |
2.1% |
| Wegener's Granulomatosis |
1.9% |
| Nausea |
1.8% |
| Chemotherapy |
1.8% |
| Colorectal Cancer |
1.7% |
| Drug Exposure Via Mother |
1.7% |
| Prophylaxis |
1.7% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Pancreatic Carcinoma |
1.3% |
|
| Vomiting |
9.9% |
| Erythrosis |
7.3% |
| Pyrexia |
7.3% |
| Cytolytic Hepatitis |
6.6% |
| Acute Generalised Exanthematous Pustulosis |
6.0% |
| Urticaria |
6.0% |
| Haemorrhage |
5.3% |
| Death |
4.6% |
| Hypothyroidism |
4.6% |
| Malaise |
4.6% |
| Pancreatitis Acute |
4.6% |
| Hypertriglyceridaemia |
4.0% |
| Pruritus |
4.0% |
| Renal Failure Acute |
4.0% |
| Respiratory Distress |
4.0% |
| Thrombocytopenia |
4.0% |
| Cardiac Arrest |
3.3% |
| Encephalopathy |
3.3% |
| Paraesthesia |
3.3% |
| Premature Baby |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
18.5% |
| Premedication |
7.9% |
| Prophylaxis Of Nausea And Vomiting |
5.0% |
| Breast Cancer |
5.0% |
| Prophylaxis |
4.7% |
| Nausea |
4.4% |
| Non-small Cell Lung Cancer |
3.8% |
| Sarcoma |
3.4% |
| Acute Lymphocytic Leukaemia |
2.9% |
| Pain |
2.7% |
| Gastric Cancer |
2.6% |
| Anxiety |
2.2% |
| Chemotherapy |
2.2% |
| Acute Myeloid Leukaemia |
1.9% |
| Vomiting |
1.8% |
| Candidiasis |
1.7% |
| Hypertension |
1.6% |
| Lymphoma |
1.5% |
| Colorectal Cancer Metastatic |
1.5% |
|
| Vomiting |
14.2% |
| Thrombocytopenia |
8.4% |
| Pyrexia |
8.0% |
| Renal Failure Acute |
6.5% |
| Toxic Epidermal Necrolysis |
5.9% |
| Weight Decreased |
5.3% |
| Febrile Bone Marrow Aplasia |
5.0% |
| General Physical Health Deterioration |
5.0% |
| Pancreatitis Acute |
4.6% |
| Renal Failure |
4.6% |
| Haemoptysis |
4.0% |
| Septic Shock |
4.0% |
| Tremor |
4.0% |
| Urticaria |
3.4% |
| Vertigo |
3.1% |
| Malaise |
2.8% |
| Nausea |
2.8% |
| Neutropenia |
2.8% |
| Rash |
2.8% |
| Small Intestinal Obstruction |
2.8% |
|
